Quantcast
CYCC

Cyclacel Pharmaceuticals, Inc. Competitors

$0.461
*  
0.019
3.96%
Get CYCC Alerts
*Delayed - data as of Aug. 21, 2019 10:09 ET  -  Find a broker to begin trading CYCC now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    CYCC Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

Cyclacel Pharmaceuticals, Inc.

CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Pfizer, Inc.
PFE: NYSE
$ 34.89 0.28 ▲ 2,175,961 $ 35.03
$ 34.86
$ 46.47
$ 33.97
15.93 192,978,265
PhaseBio Pharmaceuticals, Inc.
PHAS: NASDAQ-GM
$ 8.8799 0.50 ▲ 7,436 $ 8.8799
$ 8.275
$ 16.65
$ 2.55
NE 254,205
Phibro Animal Health Corporation
PAHC: NASDAQ-GM
$ 32.75 0.09 ▲ 28,845 $ 33.20
$ 32.56
$ 54.6202
$ 27.315
19.49 664,432
Phio Pharmaceuticals Corp.
PHIO: NASDAQ-CM
$ .3371 unch 4,117 $ .3552
$ .3371
$ 2.19
$ .27
NE 8,627
Phio Pharmaceuticals Corp.
PHIOW: NASDAQ-CM
$ .0119 unch n/a
n/a
$ .58
$ .0082
NE 15
PLx Pharma Inc.
PLXP: NASDAQ-CM
$ 5.226 -0.64 ▼ 101 $ 5.226
$ 5.226
$ 7.41
$ 1
NE 47,264
Portola Pharmaceuticals, Inc.
PTLA: NASDAQ-GS
$ 28.70 -0.19 ▼ 99,542 $ 29.235
$ 28.41
$ 37.95
$ 14.81
NE 2,191,503
Prestige Consumer Healthcare Inc.
PBH: NYSE
$ 32.94 0.40 ▲ 12,832 $ 33.05
$ 32.57
$ 41.76
$ 26.25
NE 1,654,939
Principia Biopharma Inc.
PRNB: NASDAQ-GS
$ 40.01 1.20 ▲ 33,836 $ 40.12
$ 38.37
$ 42.34
$ 22
500.13 959,080
Progenics Pharmaceuticals Inc.
PGNX: NASDAQ-GS
$ 3.82 0.15 ▲ 225,747 $ 3.85
$ 3.69
$ 8.11
$ 3.42
NE 323,718
ProPhase Labs, Inc.
PRPH: NASDAQ-CM
$ 2.03 unch n/a
n/a
$ 4
$ 1.88
NE 23,477
ProQR Therapeutics N.V.
PRQR: NASDAQ-GM
$ 8.55 0.20 ▲ 4,658 $ 8.55
$ 8.45
$ 24
$ 7.20
NE 332,364
Protagonist Therapeutics, Inc.
PTGX: NASDAQ-GM
$ 12.165 0.40 ▲ 54,695 $ 12.20
$ 11.72
$ 14.36
$ 5.4927
NE 319,696
Proteostasis Therapeutics, Inc.
PTI: NASDAQ-GM
$ .6602 0.00 ▲ 48,872 $ .68
$ .65
$ 10.38
$ .61
NE 33,736
Prothena Corporation plc
PRTA: NASDAQ-GS
$ 7.74 0.05 ▲ 8,766 $ 7.82
$ 7.64
$ 15.91
$ 7.52
NE 308,555
Provention Bio, Inc.
PRVB: NASDAQ-CM
$ 9.5385 0.29 ▲ 19,639 $ 9.56
$ 9.24
$ 22.82
$ 1.52
NE 375,216
PTC Therapeutics, Inc.
PTCT: NASDAQ-GS
$ 46.15 0.44 ▲ 11,959 $ 46.5631
$ 45.93
$ 48.99
$ 27.53
NE 2,696,591
Pulmatrix, Inc.
PULM: NASDAQ-CM
$ .854 -0.01 ▼ 918 $ .854
$ .85
$ 4.676
$ .72
NE 16,760
Puma Biotechnology Inc
PBYI: NASDAQ-GS
$ 10.73 -0.05 ▼ 63,786 $ 10.909
$ 10.5191
$ 50.75
$ 8.45
NE 414,307
Ra Pharmaceuticals, Inc.
RARX: NASDAQ-GM
$ 29.90 0.66 ▲ 41,670 $ 30.17
$ 29.29
$ 36.9632
$ 10.12
NE 1,402,400
Radius Health, Inc.
RDUS: NASDAQ-GM
$ 23.245 0.29 ▲ 37,269 $ 23.28
$ 22.89
$ 25.395
$ 12.8104
NE 1,071,757
Reata Pharmaceuticals, Inc.
RETA: NASDAQ-GM
$ 77.105 -0.01 ▼ 19,979 $ 77.93
$ 75.85
$ 104.53
$ 47.50
NE 1,882,673
Recro Pharma, Inc.
REPH: NASDAQ-CM
$ 11.84 0.29 ▲ 13,836 $ 11.86
$ 11.50
$ 11.85
$ 5.5301
NE 265,548
Redhill Biopharma Ltd.
RDHL: NASDAQ-GM
$ 7.08 unch 3,091 $ 7.08
$ 6.9245
$ 9.5725
$ 5.1291
NE 200,853
Regeneron Pharmaceuticals, Inc.
REGN: NASDAQ-GS
$ 297.69 1.66 ▲ 85,946 $ 300.51
$ 296.21
$ 442
$ 287.66
16.55 32,069,251